Articles

Poll

Podcasts

Slideshows

Videos

Hematology

FCM yielded a statistically significant improvement in Hb levels in patients with postpartum anemia over IS.

Ferric Carboxymaltose May Improve Outcomes For Subgroups of Iron Deficiency Anemia

A new systematic review finds IV iron effective for iron non-responders but calls for further studies on the causes of oral iron failure.






IV Iron Could Bridge Treatment Gaps for Children With Anemia

Anemia was linked to lower waist circumference, lower albumin levels, and treatment regimens in females, but not males.

Anemia Prevalence Higher in Females than Males Living with HIV 

Iron deficiency was more common in acute versus chronic heart failure, with notable differences in detection by numerous recommended definitions.


Rates of Iron Deficiency Differ by Clinical Definition in Heart Failure

The FDA approved an expanded label for avacincaptad pegol, removing limitations on the duration of dosing beyond 12 months.

FDA Expands Dosing Label for Avacincaptad Pegol for Geographic Atrophy

Meta-analysis suggests iron therapy lowers the risk of heart failure hospitalization and cardiovascular death in patients with chronic kidney disease.

Iron May Reduce Heart Failure Risk in CKD, but More Trials Needed

Iron administration was linked to a decrease in platelet counts, even in the absence of preexisting thrombocytosis.

Iron Replacement Therapy Resolves Thrombocytosis in Patients with Anemia

Emblaveo combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.

FDA Approves Emblaveo Combination Antibiotic Therapy for Complicated Intra-Abdominal Infections

More than 90% of patients with hemophilia B eliminated factor IX prophylaxis 4 years after treatment with etranacogene dezaparvovec (HEMGENIX) gene therapy.

Hemophilia B Gene Therapy Achieves Sustained Benefit Over 4 Years

Interim analysis of the Phase 3 FRONTIER3 trial found Mim8 well-tolerated in children with hemophilia A with and without inhibitors.